Search Press releases Keywords From To 22 Apr 2021 UCB’s zilucoplan shows no relevant effect in immune-mediated necrotizing myopathy (IMNM) Read More 20 Apr 2021 Acquisitions of own shares and Disposals of own shares Read More 16 Apr 2021 UCB showcases new research at the 73rd American Academy of Neurology Annual Meeting to demonstrate broad neurology leadership and future portfolio Read More 14 Apr 2021 Notice of Early Redemption - €350 million € 1.875% fixed rate notes due 2 April 2022 Read More 9 Apr 2021 Acquisitions of own shares and Disposals of own shares Read More 7 Apr 2021 Transparency notification UCB SA/NV Read More Pagination First page Previous page Previous … Page 46 Page 47 Page 48 Page 49 Current page 50 Page 51 Page 52 Page 53 Page 54 … Page 50 of 67 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
